Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?

Canadian Journal of Urology

Volumn 19, Issue 3, 2012, Pages 6269-6273

  Gravas, Stavros ^a   Efstathiou, Kostas ^a   Zachos, Ioannis ^a   Melekos, Michael D ^a   Tzortzis, Vassilios ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Bladder cancer; Fluorescence cystoscopy; Hexaminolevulinate hydrochloride; Learning curve; Photodynamic diagnosis

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHOTOSENSITIZING AGENT;

AGED; ARTICLE; BLADDER TUMOR; CARCINOMA; CLINICAL COMPETENCE; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMAN; LABORATORY DIAGNOSIS; LEARNING CURVE; LIGHT; MALE; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA; CLINICAL COMPETENCE; CYSTOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; FLUORESCENCE; HUMANS; LEARNING CURVE; LIGHT; MALE; MIDDLE AGED; OBSERVER VARIATION; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84871898660     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schmidbauer J, Marberger M. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit? Curr Opin Urol 2007;17(5):347-351. Gravas ET AL. 6273
2. Jichlinski P, Guillou L, Karlsen SJ et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 2003;170(1): 226-229.
3. Jocham D, Witjes F, Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005;174(3):862-866.
4. Fradet Y, Grossman HB, Gomella L, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007;178(1): 68-73.
5. Schmidbauer J, Witjes F, Schmeller N et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171(1):135-138.
6. Grossman HB, Gomella L, Fradet Y et al. A phase III multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007;178(1):62-67.
7. Loidl W, Schmidbauer J, Susani M et al. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?. Eur Urol 2005;47(3): 323-326.
8. Witjes JA, Moonen PMJ, van der Heijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective phase II study. Eur Urol 2005;47(3):319-322.
9. Geavlete B, Jecu M, Multescu R et al. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study. Urology 2010;76(3):664-669.
10. Kausch I, Sommerauer M, Montorsi F et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010;57(4):595-606.
11. Babjuk M, Oosterlinck W, Sylvester R et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 Update. Eur Urol 2011;59(6):997-1008.
12. Zaak D, Wieland WF, Stief CG et al. Routine use of photodynamic diagnosis of bladder cancer: practical and economic issues. Eur Urol Suppl 2008;7(7):536-541.
13. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008;53(6):1138-1148.
14. Witjes JA. Bladder carcinoma in situ in 2003: state of the art. Eur Urol 2004;45(2):142-146.
15. Witjes JA, Palou-Redorta J, Jacqmin D et al. Hexaminolevulinateguided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010;57(4):607-614.
16. Herrell SD, Smith JA Jr. Robotic-assisted laparoscopic prostatectomy: what is the learning curve? Urology 2005;66(5 Suppl):105-107.
17. Draga ROP, Grimbergen MCM, Kok ET et al. Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guerin immunotherapy and mitomycin C intravesical therapy. Eur Urol 2010;57(4):655-660.
18. Hendricksen K, Moonen PM, der Heijden AG, Witjes JA. False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression? World J Urol 2006;24(5): 597-601.
19. Jichlinski P, Leisinger H-J. Fluorescence cystoscopy in the management of bladder cancer: A help for the urologist. Urol Int 2005;74(2):97-101.
20. Bordier B, Mazerolles C, Malavaud B. Photodynamic diagnosis in non-muscle-invasive bladder cancer. Eur Urol Suppl 2010;9(3): 411-418.
21. Shah HN, Mahajan AP, Sodha HS et al. Evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 2007; 177(4):1468-1474.